Assaf Gershoni

Dr. Assaf Gershoni


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
AGAssaf Gershoni
Assaf Gershoni
IVIgor Vainer
Igor Vainer
OROlga Reitblat
Olga Reitblat
FMFrancis B. Mimouni
Francis B. Mimouni
ELEitan Livny
Eitan Livny
MMMichael Mimouni
Michael Mimouni
Background: The purpose of this study was to compare the h-index, and subsequently the research productivity, among different ophthalmic subspecialties in the United States. Methods: A cohort of over 15,000 academic ophthalmologists residing in the United States (US) was identified out of the physician list of the American Academy of Ophthalmology. Of them, 1000 ophthalmologists with at least one publication were randomly retrieved, 100 in each of the following 10 subspecialties: cataract, cornea/external disease, glaucoma, medical retina, neuro-ophthalmology, pediatric ophthalmology, plastic/reconstructive ophthalmology, refractive surgery, retina/vitreous surgery and uveitis. Data collected included: number of published papers, h-index score, annual increase in h-index and the mean number of authors on each paper. Results: The mean h-index amongst all subspecialties was 9.87 ± 13.90, and the mean average annual increase in h-index was 0.22 ± 0.21. The mean number of papers published was 37.20 ± 80.08 and the mean number of authors on each paper was 3.39 ± 0.84. Uveitis was the most prolific subspecialty in mean number of papers (74.78 ± 131.37), in mean h-index (16.69 ± 20.00) and in mean annual increase in h-index (0.35 ± 0.28). The least fertile subspecialty with regards to research was cataract with 11.06 ± 27.65 mean number of papers, a mean h-index of 3.89 ± 5.84, and a mean annual increase in h-index of 0.11 ± 0.11. Conclusions: This study describes the research productivity in each ophthalmic subspecialty in the US, thus providing information on the research performance of each field and on the expected academic accomplishments within it.

4 January 2021 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
AGAssaf Gershoni
Assaf Gershoni
ATAlon Tiosano
Alon Tiosano
OGOren Gabbay
Oren Gabbay
MSMor Schlesinger
Mor Schlesinger
UEUri Elbaz
Uri Elbaz
GDGad Dotan
Gad Dotan

29 October 2020 in Journal of Glaucoma
Verified
Journal Article
Closed access
EBEdward Md Barayev
Edward Md Barayev
NGNoa Geffen
Noa Geffen
YNYoav Nahum
Yoav Nahum
AGAssaf Gershoni
Assaf Gershoni
Precis: Brand glaucoma medication prices vastly increased in the United States over the past 7 years, despite a reduction in eye-care providers’ tendency to prescribe brand medications over generics. Purpose: Determine the changes in prices of brand and generic glaucoma medications and to identify changes in eye-care providers prescribing patterns since 2013. Materials and Methods: The National Average Drug Acquisition Cost (NADAC) database (2013-2019) was used analyze per-unit drug price. Medicare Part D prescriber profile was used to identify eye-care providers prescribing patterns between 2013 and 2017. Results: Brand-name medication prices increased by 59% between 2013 and 2019, while generic medications decreased by 22%. Brand-name drugs were 13 to 162 times more expensive than their generic counterparts. Eye-care Providers prescribed 25% less brand name medications in 2017 compared with 2013. Conclusion: Brand glaucoma medication prices vastly increased in the United States over the past 7 years, despite a reduction in eye-care providers’ tendency to prescribe brand medications over generics. A change in government policy, allowing Medicare medication prices negotiations, could greatly reduce health expenditure on glaucoma treatment.

15 March 2021 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
EBEdward Barayev
Edward Barayev
OBOfri Vorobichik Berar
Ofri Vorobichik Berar
GDGad Dotan
Gad Dotan
ASAlon Skaat
Alon Skaat
OGOrly Gal-Or
Orly Gal-Or
DGDan Gaton
Dan Gaton
To estimate the extent of WhatsApp utilization using text and media messages for inter-physician consultations among ophthalmologists (residents and specialists) at various clinical settings and its perceived benefits for ophthalmologists and their patients. We also aimed to detect obstacles that concern ophthalmologists when using WhatsApp as a consultation platform. This was a cross-sectional study using a self-administered survey through Google Forms, which was sent to 660 practicing ophthalmologists during April to May 2020. One hundred and ninety-two ophthalmologists completed the questionnaire, 151 of which (78.6%) were specialists and 41 (21.4%) were residents. Most ophthalmologists reported using WhatsApp at least once a day for both personal and professional use. Residents reported lower rates of contacting patients using WhatsApp than specialists (1.51 ± 0.98 vs 2.72 ± 1.32, p < 0.001). Respondents reported WhatsApp consultations frequently replaced referrals of patients to other physicians, with a median of once a week. 97.8% of residents and 91.4% of specialists reported the ability to share media is a major advantage of WhatsApp over other medias, followed by rapid responses for consultations. Many ophthalmologists already use WhatsApp as a tool for professional consultations with other providers, mainly thanks to its simplicity and wide availability. Residents use it more frequently than specialists, and ranked it higher when asked how much WhatsApp has improved the clinical setting. Policy makers should address concerns brought up by physicians, such as documentation in medical records and proper compensation for consulting ophthalmologists during and after work hours.

4 January 2023 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
EBEdward Barayev
Edward Barayev
AMAmit Meshi
Amit Meshi
AGAssaf Gershoni
Assaf Gershoni
OSOri Segal
Ori Segal
ADAssaf Dotan
Assaf Dotan
OGOrly Gal-Or
Orly Gal-Or
Purpose: To compare morphologic characteristics of type 1 macular neovascularization (MNV) flow pattern in treatment-naïve and previously treated patients with age-related macular degeneration (AMD) as assessed by optical coherence tomography angiography (OCTA). Study Design: Cross-sectional study Materials and Methods: Macular OCT angiography images were acquired using RTVue XR Avanti with AngioVue. Distinct morphologic biomarkers and quantifiable features of the neovascular membranes were studied on en-face projection images comparing treatment-naïve and previously treated patients. Results: The study included 68 eyes of 58 patients. Among them, 24 eyes were treatment-naïve, and the remaining eyes had received a mean of 19.6 injections. Immature lesions were more associated with treatment-naïve eyes and hyper-mature lesions were associated with previously treated eyes (p = 0.005). Tangle pattern was associated with treatment-naïve eyes (p = 0.013), whereas mature core vessels and sea fan pattern were associated more with previously treated eyes (p = 0.001 and p = 0.044, respectively). Vascular density of the neovascular membrane was higher in the treatment-naïve group (p = 0.036) and the average MNV area was similar between the 2 groups (p = 0.683). Conclusions: Based on OCTA, morphologic biomarkers of type 1 MNV might be an indication of previous treatment. The MNV pattern can improve our understanding of its maturation under anti-VEGF treatment and might be valuable to better guide therapeutic decisions and provide more personalized care to patients with AMD.

21 January 2024 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
SNSara Naftali
Sara Naftali
KRKeren Della Rocca
Keren Della Rocca
AGAssaf Gershoni
Assaf Gershoni
RERita Ehrlich
Rita Ehrlich
ARAnat Ratnovsky
Anat Ratnovsky